Artwork

Sisällön tarjoaa Foresight Institute. Foresight Institute tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Vision Weekend France: Biotech Panel

37:43
 
Jaa
 

Manage episode 405339924 series 2943147
Sisällön tarjoaa Foresight Institute. Foresight Institute tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

t

Panellists: Alex Fedintsev, Leon Peshkin, Yuri Deigin, and Aleksandra Singer.

Recorded at Vision Weekend France 2023.


Key Highlights

  • They discussed the field's growth in public acceptance and funding over the past five years – they noted that, whilst reprogramming and longevity research are advancing, overall outcomes in the field haven't been as fruitful as hoped. For example, no groundbreaking concepts have emerged since reprogramming. However, they expressed optimism about the field's future, expecting gradual progress.
  • The panellists identified organ replacement, including preemptive strategies, as a key research area, as well as the potential for growth in artificially creating organs.
  • The potential integration of AI and machine learning in longevity biotech, particularly in projects like Alto Labs, was discussed.
  • They raised questions about the timeline and impact of ageing on future generations.
  • The discussion ended with an acknowledgement that, despite the optimism, much work remains in longevity biotech research.

About Foresight Institute

Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.


Allison Duettmann

The President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".


Get Involved with Foresight:

Follow Us: Twitter | Facebook | LinkedIn


Note: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

168 jaksoa

Artwork
iconJaa
 
Manage episode 405339924 series 2943147
Sisällön tarjoaa Foresight Institute. Foresight Institute tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

t

Panellists: Alex Fedintsev, Leon Peshkin, Yuri Deigin, and Aleksandra Singer.

Recorded at Vision Weekend France 2023.


Key Highlights

  • They discussed the field's growth in public acceptance and funding over the past five years – they noted that, whilst reprogramming and longevity research are advancing, overall outcomes in the field haven't been as fruitful as hoped. For example, no groundbreaking concepts have emerged since reprogramming. However, they expressed optimism about the field's future, expecting gradual progress.
  • The panellists identified organ replacement, including preemptive strategies, as a key research area, as well as the potential for growth in artificially creating organs.
  • The potential integration of AI and machine learning in longevity biotech, particularly in projects like Alto Labs, was discussed.
  • They raised questions about the timeline and impact of ageing on future generations.
  • The discussion ended with an acknowledgement that, despite the optimism, much work remains in longevity biotech research.

About Foresight Institute

Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.


Allison Duettmann

The President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".


Get Involved with Foresight:

Follow Us: Twitter | Facebook | LinkedIn


Note: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

168 jaksoa

All episodes

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas